Schedule 13D ownership disclosure

Forma Therapeutics Holdings, Inc.,

Security class unavailable · CUSIP: 34633R104

Event date: 2022-08-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,040,309
Percent of class
18.8800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-097525
Form type
SC 13D/A
Filer
Forma Therapeutics Holdings, Inc.
CIK
CIK 1538927
Filed
Sep 02, 2022
Reporting period
Aug 31, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub